Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [8247]

Researchers identify enzyme that suppresses immune system in breast cancer

Researchers identify enzyme that suppresses immune system in breast cancer

New treatment for pancreatic cancer

New treatment for pancreatic cancer

EHA 2019: Burning out the T-ALL engine: NADK is a new therapeutic target in T-cell Acute Lymphoblastic Leukaemia

EHA 2019: Burning out the T-ALL engine: NADK is a new therapeutic target in T-cell Acute Lymphoblastic Leukaemia

Cancer-killing virus boosts immunotherapy in hard-to-treat cancer

Cancer-killing virus boosts immunotherapy in hard-to-treat cancer

Cardiac toxicity risk factors identified with relapsed multiple myeloma therapy

Cardiac toxicity risk factors identified with relapsed multiple myeloma therapy

CNIO researchers find effective drug combinations for glioblastoma in mice

CNIO researchers find effective drug combinations for glioblastoma in mice

$EHA 2019: Imetelstat in lower risk myelodysplastic syndromes refractory to erythropoietic stimulating agents$

EHA 2019: Imetelstat in lower risk myelodysplastic syndromes refractory to erythropoietic stimulating agents

EHA 2019: Introduction of a new fixed-duration targeted therapy with venetoclax plus obinutuzumab in previously untreated patients with chronic lymphocytic leukaemia and coexisting comorbidities

EHA 2019: Introduction of a new fixed-duration targeted therapy with venetoclax plus obinutuzumab in previously...

A heart failure drug to treat leukaemia: a promising new therapeutic approach

A heart failure drug to treat leukaemia: a promising new therapeutic approach

Radiation plus chemotherapy doesn't improve endometrial cancer recurrence-free survival

Radiation plus chemotherapy doesn't improve endometrial cancer recurrence-free survival

More from ecancer